Nuclear Medicine: Page 17

IsoRay completes merger with Viewpoint Molecular Targeting

By AuntMinnie.com staff writers

Medical isotope developer IsoRay has completed its merger with Viewpoint Molecular Targeting. The deal closed on February 3.

February 5, 2023

Russia breaks ground on nuclear isotope plant

By AuntMinnie.com staff writers

Russian state nuclear energy firm Rosatom has begun construction of a $129 million nuclear research reactor for medical isotope production in Obninsk, a city in the country's Kaluga region, according to Russian media outlets.

January 29, 2023

Siemens secures Health Canada clearance for SPECT/CT system

By AuntMinnie.com staff writers

Siemens Healthineers has received Health Canada clearance for its Symbia Pro.specta SPECT/CT system.

January 22, 2023

NorthStar produces first Mo-99 batch at new facility

By AuntMinnie.com staff writers

NorthStar Medical Isotopes has produced the first batch of molybdenum-99 (Mo-99) at its recently completed therapeutic radioisotope production facility in Beloit, WI.

January 10, 2023

PSMA-PET shows value in primary staging of prostate cancer

By Will Morton

Prostate-specific membrane antigen (PSMA) PET/CT imaging can reveal metastatic bone cancer lesions in prostate cancer patients that may be undetected by conventional bone scintigraphy, according to a group in the Netherlands.

January 5, 2023

NorthStar and Inhibrx ink deal on radiopharmaceutical development

By AuntMinnie.com staff writers

NorthStar Medical Radioisotopes and biopharmaceutical company Inhibrx have inked a collaboration agreement for the development and production of new radiopharmaceuticals.

January 3, 2023

Fast acquisition techniques cut SPECT/CT bone scan times by half

By Will Morton

Whole-body SPECT/CT bone scan times to detect metastatic tumors in prostate cancer patients could be cut by half with the use of faster acquisition techniques, according to a study published December 12 in EJNMMI Physics.

December 18, 2022

Companies ink deal to develop OncoFAP-23

By AuntMinnie.com staff writers

Philochem has signed agreements with Seibersdorf Laboratories and Isotopia Molecular Imaging to develop its lutetium-177 OncoFAP-23 radiopharmaceutical for cancer treatment.

December 13, 2022

FBPA-PET can differentiate between malignant and benign lesions

By Will Morton

PET/CT imaging with a boron-based radiotracer is superior to that with standard F-18 FDG for differentiating malignant from benign lesions, according to a study published December 5 in Annals of Nuclear Medicine.

December 7, 2022

11 organizations join IAEA's Rays of Hope initiative

By AuntMinnie.com staff writers

The International Atomic Energy Agency (IAEA) has signed on 11 of the largest professional societies in cancer care to help improve access to radiotherapy worldwide through its Rays of Hope initiative.

December 6, 2022

3D printing technology could increase Mo-99 production

By Will Morton

Researchers at the National Centre for Nuclear Research in Swierk, Poland, have secured a patent for the use of 3D printing technology to increase production of molybdenum-99 (Mo-99) for medical imaging.

December 5, 2022

GE leans into improving patient outcomes, healthcare efficiency

By Erik L. Ridley and Kate Madden Yee

CHICAGO - At this year's RSNA meeting, GE Healthcare is focusing on two goals: improving patient outcomes and boosting the efficiency of the healthcare enterprise. Promotion of these themes comes just weeks before GE is set to spin off its healthcare division into a standalone firm to be called GE HealthCare, which it plans to do in January.

November 28, 2022

Previous Page

Page 17 of 440

Next Page